Yuzhuo Z Wang

60PUBLICATIONS
279CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Sep 24, 2026
Correction: Maylin et al. Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer. Cells 2024, 13, 1999.

|Jul 30, 2026
DNMT3B drives neuroendocrine lineage plasticity and aggressive progression in prostate cancer.

|Apr 13, 2026
PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges.

Takashi Matsuoka, Shusuke Akamatsu, Christopher J Ong

|Oct 27, 2025
Transcription Factor Dynamics in Neuroendocrine Prostate Cancer Development.

Yu Wang, Yuzhuo Wang

|Jun 04, 2025
Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiation.

Yuchao Ni, Dong Lin, Mingchen Shi

|May 09, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.

Yen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik

Pageof 10

Frequent Collaborators

7 joint publications

Martin Gleave

5 joint publications

Nelson K Y Wong

4 joint publications

Dong Lin

4 joint publications

Francesco Crea